QTREX Quantum Ltd. (QTEX)
QTREX Quantum Ltd. (QTEX) Stock Price, Analysis & Data
Keine Daten verfügbar
| Geld | 0.67 |
| Marktkapitalisierung | 52.36 Mio |
| Umsatz (TTM) | 289K |
| Nettogewinn (TTM) | -13.22 Mio |
| Beta | 4.28 |
| EPS (ttm) | -0.45 |
| KGV (TTM) | n/a |
| Forward-KGV | n/a |
| KBV (TTM) | 14.46 |
| KUV (TTM) | 181.18 |
| Earnings Date | n/a |
| Brief | 1.23 |
| Volumen | 776,825 |
| Ø Vol. (20D) | 30,844,001 |
| Eröffnung | 0.94 |
| Vortagesschluss | 0.98 |
| Tagesspanne | 0.93 - 0.97 |
| 52-Wk Range | 0.28 - 3.85 |
| Analyst | n/a |
| Kursziel | n/a |
| Dividenden | n/a |
| Ex-Dividenden-Datum | n/a |
Über QTEX
QTREX Quantum Ltd., engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure and advanced connectivity solutions for the quantum computing industry in Israel and USA. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. It also offers HYLA blood sensor, which is designed to perform...
Finanzielle Entwicklung
Im Jahr 2025 betrug der Umsatz von QTREX Quantum 289K, ein Anstieg von undefined% im Vergleich zum Vorjahr (0). Der Gewinn lag bei -13.22 Mio, ein Anstieg von 19.61 %.
Finanzberichte
vor 3 Wochen · Simply Wall St.
QTREX Quantum (QTEX) Files New Shelves, Is The Stock Already Overvalued?QTREX Quantum (NasdaqCM:QTEX) moved back into focus after filing two shelf registrations totaling about US$12.6 million in ordinary shares, including an ESOP related component. This development raises...
